156 related articles for article (PubMed ID: 9008279)
1. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.
Lucey DR; Pinto LA; Bethke FR; Rusnak J; Melcher GP; Hashemi FN; Landay AL; Kessler HA; Paxton RJ; Grabstein K; Shearer GM
Clin Diagn Lab Immunol; 1997 Jan; 4(1):43-8. PubMed ID: 9008279
[TBL] [Abstract][Full Text] [Related]
2. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15.
Seder RA; Grabstein KH; Berzofsky JA; McDyer JF
J Exp Med; 1995 Oct; 182(4):1067-77. PubMed ID: 7561680
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
Loubeau M; Ahmad A; Toma E; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro.
Bayard-McNeeley M; Doo H; He S; Hafner A; Johnson WD; Ho JL
Clin Diagn Lab Immunol; 1996 Sep; 3(5):547-53. PubMed ID: 8877133
[TBL] [Abstract][Full Text] [Related]
5. The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.
Stine KC; Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ
Cell Immunol; 1991 Aug; 136(1):165-72. PubMed ID: 1905587
[TBL] [Abstract][Full Text] [Related]
6. Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 in HIV-1 p24-activated whole blood cultures: relationship with the viral load in plasma.
Hober D; Benyoucef S; Chieux V; De Groote D; De La Tribonnière X; Bocket L; Lion G; Mouton Y; Wattré P
Scand J Immunol; 1999 Jul; 50(1):83-90. PubMed ID: 10404056
[TBL] [Abstract][Full Text] [Related]
7. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
Qian JX; Lee SM; Suen Y; Knoppel E; van de Ven C; Cairo MS
Blood; 1997 Oct; 90(8):3106-17. PubMed ID: 9376592
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage.
Perales MA; Skolnik PR; Lieberman J
AIDS Res Hum Retroviruses; 1996 May; 12(8):659-68. PubMed ID: 8744576
[TBL] [Abstract][Full Text] [Related]
9. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Clerici M; Lucey DR; Berzofsky JA; Pinto LA; Wynn TA; Blatt SP; Dolan MJ; Hendrix CW; Wolf SF; Shearer GM
Science; 1993 Dec; 262(5140):1721-4. PubMed ID: 7903123
[TBL] [Abstract][Full Text] [Related]
10. Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs.
Heaton KM; Ju G; Grimm EA
Ann Surg Oncol; 1994 May; 1(3):198-203. PubMed ID: 7842289
[TBL] [Abstract][Full Text] [Related]
11. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
[TBL] [Abstract][Full Text] [Related]
13. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.
Ozdemir O; Ravindranath Y; Savaşan S
J Immunother; 2005; 28(1):44-52. PubMed ID: 15614044
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation.
Jones ML; Young JM; Huang QR; Puls RL; Webber CA; Benson EM
AIDS Res Hum Retroviruses; 2003 Apr; 19(4):283-92. PubMed ID: 12804004
[TBL] [Abstract][Full Text] [Related]
16. The role of IL-15 in challenging Acquired Immunodeficiency Syndrome.
d'Ettorre G; Andreotti M; Ceccarelli G; Galluzzo CM; Mallano A; Massetti AP; Tierno F; Stella S; Amici R; Vella S; Mastroianni CM; Vullo V
Cytokine; 2012 Jan; 57(1):54-60. PubMed ID: 22055728
[TBL] [Abstract][Full Text] [Related]
17. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity.
Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M
Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin (IL)-15 priming on IL-12 and interferon-gamma production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors.
Parayath KE; Harrison TS; Levitz SM
J Infect Dis; 2000 Feb; 181(2):733-6. PubMed ID: 10669365
[TBL] [Abstract][Full Text] [Related]
19. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
[TBL] [Abstract][Full Text] [Related]
20. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells.
Ríos Z; Ríos EO; Garcia MI; De Leon C; Guzman LM; Rodriguez W; Romero D; Hunter R
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S93-101. PubMed ID: 8574153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
